{
    "clinical_study": {
        "@rank": "3250", 
        "acronym": "D-status", 
        "arm_group": [
            {
                "arm_group_label": "Vitamin D dose 1", 
                "arm_group_type": "Experimental", 
                "description": "Vitamin D dose 1"
            }, 
            {
                "arm_group_label": "Vitamin D dose 2", 
                "arm_group_type": "Experimental", 
                "description": "Vitamin D dose 2"
            }, 
            {
                "arm_group_label": "Vitamin D dose 3", 
                "arm_group_type": "Experimental", 
                "description": "Vitamin D dose 3"
            }, 
            {
                "arm_group_label": "observational", 
                "arm_group_type": "No Intervention"
            }
        ], 
        "brief_summary": {
            "textblock": "The objectives of this study are 1) to assess the prevalence of vitamin D deficiency in a\n      group of sub elite athletes and 2) to identify seasonal changes in vitamin D status and the\n      effect that supplementation may have during the course of a year.\n\n      The study is a double blinded parallel study design. Study population: 175 elite/ sub elite\n      athletes, male and female, aged 18-60y, from a variety of sport disciplines"
        }, 
        "brief_title": "Vitamin D Status and Supplementation in Athletes", 
        "completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Vitamin D Deficiency", 
        "condition_browse": {
            "mesh_term": "Vitamin D Deficiency"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  athletes\n\n          -  19-60y\n\n        Exclusion Criteria:\n\n          -  subjects who take vitamin D supplements"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "60 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "175", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 10, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02008201", 
            "org_study_id": "D-status"
        }, 
        "intervention": {
            "arm_group_label": [
                "Vitamin D dose 1", 
                "Vitamin D dose 2", 
                "Vitamin D dose 3"
            ], 
            "intervention_name": "vitamin D", 
            "intervention_type": "Dietary Supplement"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Vitamin D", 
                "Ergocalciferols", 
                "Vitamins"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": "dose-response study", 
        "lastchanged_date": "December 5, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Wageningen", 
                    "country": "Netherlands"
                }, 
                "name": "Wageningen University"
            }
        }, 
        "location_countries": {
            "country": "Netherlands"
        }, 
        "number_of_arms": "4", 
        "official_title": "Vitamin D Status and Supplementation in Elite Athletes", 
        "overall_official": {
            "affiliation": "Wageningen University", 
            "last_name": "Lisette de Groot, Prof. Dr.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "The Netherlands: Wageningen University", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Change in serum 25(OH)D", 
            "safety_issue": "No", 
            "time_frame": "Every 3 months during one year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02008201"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Wageningen University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Wageningen University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Bio-availability Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}